Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cresco Labs (CRLBF) Enterprise Value (2019 - 2026)

Cresco Labs filings provide 8 years of Enterprise Value readings, the most recent being -$155.4 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 72.86% to -$155.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$155.4 million, a 58.02% decrease, with the full-year FY2025 number at -$179.0 million, down 98.67% from a year prior.
  • Enterprise Value hit -$155.4 million in Q1 2026 for Cresco Labs, up from -$179.0 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of $34.5 million in Q1 2022 to a low of -$209.1 million in Q2 2024.
  • Median Enterprise Value over the past 5 years was -$86.7 million (2025), compared with a mean of -$91.3 million.
  • Biggest five-year swings in Enterprise Value: surged 85.69% in 2022 and later plummeted 372.98% in 2023.
  • Cresco Labs' Enterprise Value stood at -$39.4 million in 2022, then tumbled by 372.98% to -$186.1 million in 2023, then surged by 51.59% to -$90.1 million in 2024, then tumbled by 98.67% to -$179.0 million in 2025, then rose by 13.21% to -$155.4 million in 2026.
  • The last three reported values for Enterprise Value were -$155.4 million (Q1 2026), -$179.0 million (Q4 2025), and -$121.5 million (Q3 2025) per Business Quant data.